NCT01547299 2018-10-23Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate CancerPfizerPhase 2 Completed52 enrolled 36 charts